Sienna Biopharmaceuticals Inc. (SNNA)

11.25 +0.22 (+1.995%)

IEX Real-Time Price

October 19, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 11.03

Price Open 11.03

Volume: 68,472

Avg Volume: 74,088

Market Cap: 234M

P/E Ratio -3.19

52 Wk Range 9.83-25.71



SNNA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
19.16M
998,856
11.72
5.21%

2018-09-14
19.16M
998,980
11.86
5.22%

2018-08-31
19.16M
1.15M
16.88
5.98%

2018-08-15
19.16M
1.22M
24.34
6.35%




SNNA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-09
Q2 2018
N/A
-0.75 (1)
-1.00
-0.25

2018-05-14
Q1 2018
N/A
-0.72 (1)
-0.85
-0.13

2018-03-15
Q4 2017
N/A
0.00 (0)
-0.56
0.00

2018-03-08
Q4 2017
N/A
0.00 (0)
-0.56
0.00

News

Your Daily Pharma Scoop: ESPR Phase 3 Positive, FDA Rejects Volanesorsen, Ozempic Succeeds (2018-08-29 13:18 SeekingAlpha)

Stocks in News: ESPR Esperion announces positive results from phase 3 bempedoic acid/ezetimibe combination pill study Discussion: Positive top-line results from the pivotal Phase 3 trial of Esperions ( ESPR ) bempedoic acid/ezetimibe combination pill study ( 1…

 


Statistics

Shares Outstanding: 20.8M

Top 15 Institution Percent: 76.20

Price To Sales: N/A

Price To Book: 4.13

Revenue: N/A

Gross Profit: N/A

Cash: 88.60M

Debt: N/A

Return On Assets: -57.02

Return On Equity: 57707.56

Profit Margin: N/A

Price History

Beta: 0.59

50-day Moving Avg: 14.92

200-day Moving Avg: 16.48

YTD Change: -32.15

5-day Change: 8.80

1-month Change: -30.12

3-month Change: -27.88

6-month Change: -43.78

1-year Change: -47.80

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Sienna Biopharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.SiennaBio.com

Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.